Meghmani Organics Ltd is Rated Sell

Jan 05 2026 10:15 AM IST
share
Share Via
Meghmani Organics Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 05 January 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.



Current Rating and Its Significance


MarketsMOJO currently assigns Meghmani Organics Ltd a 'Sell' rating, indicating a cautious stance towards the stock. This rating suggests that investors should consider reducing exposure or avoiding new purchases at this time, based on a comprehensive evaluation of the company’s quality, valuation, financial trends, and technical indicators. The rating was revised on 01 January 2026, reflecting a modest improvement from a previous 'Strong Sell' grade, with the Mojo Score increasing from 29 to 32. Despite this, the 'Sell' rating underscores ongoing challenges facing the company.



Here’s How Meghmani Organics Looks Today


As of 05 January 2026, Meghmani Organics Ltd remains a small-cap player in the Pesticides & Agrochemicals sector, with a Mojo Score of 32.0. The company’s financial and market data reveal a mixed picture, with some positive trends tempered by structural weaknesses and market headwinds.



Quality Assessment


The quality grade for Meghmani Organics is below average, reflecting concerns about the company’s fundamental strength. The latest data shows a negative compound annual growth rate (CAGR) of -18.02% in operating profits over the past five years, signalling deteriorating profitability. Additionally, the average Return on Equity (ROE) stands at a modest 6.03%, indicating limited efficiency in generating returns from shareholders’ funds. These metrics highlight challenges in sustaining competitive advantage and operational excellence.



Valuation Perspective


On the valuation front, Meghmani Organics is currently rated as very attractive. This suggests that the stock is trading at a price level that may offer value relative to its earnings and asset base. For value-oriented investors, this could present an opportunity to acquire shares at a discount compared to peers or historical averages. However, valuation attractiveness alone does not offset the risks posed by weak fundamentals and market sentiment.




Register here to know the latest call on Meghmani Organics Ltd



  • - Fundamental Analysis

  • - Technical Signals

  • - Peer Comparison


Register Now →




Financial Trend


The financial grade for Meghmani Organics is positive, reflecting some encouraging signs in recent performance. Despite the long-term decline in operating profits, the company has shown resilience in certain quarters. However, the overall trend remains challenging, with the stock delivering a negative 20.98% return over the past year as of 05 January 2026. This underperformance extends over multiple periods, including a 36.32% decline over six months and a 23.78% drop in the last three months, signalling persistent headwinds.



Technical Analysis


Technically, Meghmani Organics is graded bearish, indicating downward momentum in the stock price. The one-day change on 05 January 2026 was -0.48%, and the stock has struggled to maintain upward momentum despite a modest 1.80% gain over the past week. The bearish technical grade suggests that short-term price action remains weak, which may deter momentum investors and traders.



Investor Participation and Market Sentiment


Institutional investor participation has declined recently, with a 0.83% reduction in their stake over the previous quarter, leaving institutions holding just 1.52% of the company’s shares. Given that institutional investors typically possess greater analytical resources and market insight, their reduced involvement may reflect concerns about the company’s prospects. This trend can influence market sentiment negatively and contribute to the stock’s subdued performance.



Comparative Performance


Meghmani Organics has consistently underperformed its benchmark, the BSE500, over the last three years. The stock’s returns have lagged behind the broader market, with a cumulative negative trend that investors should carefully consider. This persistent underperformance highlights the challenges the company faces in regaining investor confidence and delivering sustainable growth.




Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!



  • - Long-term growth stock

  • - Multi-quarter performance

  • - Sustainable gains ahead


Invest for the Long Haul →




What This Rating Means for Investors


For investors, the 'Sell' rating on Meghmani Organics Ltd signals caution. While the valuation appears attractive, the company’s below-average quality, bearish technical outlook, and mixed financial trends suggest that risks remain elevated. Investors should weigh these factors carefully before considering exposure to the stock. The rating advises a conservative approach, potentially reducing holdings or avoiding new investments until clearer signs of fundamental improvement emerge.



Summary of Key Metrics as of 05 January 2026


To summarise, Meghmani Organics Ltd’s key metrics include:



  • Mojo Score: 32.0 (Sell grade)

  • Operating Profit CAGR (5 years): -18.02%

  • Average Return on Equity: 6.03%

  • Institutional Holding: 1.52%, down 0.83% last quarter

  • Stock Returns: 1 Year -20.98%, 6 Months -36.32%, 3 Months -23.78%

  • Technical Grade: Bearish

  • Valuation Grade: Very Attractive



These figures provide a comprehensive snapshot of the company’s current standing and underpin the rationale behind the 'Sell' rating.



Looking Ahead


Investors should monitor Meghmani Organics’ quarterly results and sector developments closely. Improvements in operating profit growth, enhanced profitability, and stabilisation of institutional interest would be key indicators to watch for any potential shift in the stock’s outlook. Until then, the cautious stance reflected in the current rating remains prudent.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News